Correlation Between VectivBio Holding and Iteos Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VectivBio Holding and Iteos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VectivBio Holding and Iteos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VectivBio Holding AG and Iteos Therapeutics, you can compare the effects of market volatilities on VectivBio Holding and Iteos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VectivBio Holding with a short position of Iteos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of VectivBio Holding and Iteos Therapeutics.

Diversification Opportunities for VectivBio Holding and Iteos Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between VectivBio and Iteos is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding VectivBio Holding AG and Iteos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iteos Therapeutics and VectivBio Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VectivBio Holding AG are associated (or correlated) with Iteos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iteos Therapeutics has no effect on the direction of VectivBio Holding i.e., VectivBio Holding and Iteos Therapeutics go up and down completely randomly.

Pair Corralation between VectivBio Holding and Iteos Therapeutics

If you would invest  744.00  in Iteos Therapeutics on February 15, 2025 and sell it today you would earn a total of  53.00  from holding Iteos Therapeutics or generate 7.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

VectivBio Holding AG  vs.  Iteos Therapeutics

 Performance 
       Timeline  
VectivBio Holding 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days VectivBio Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, VectivBio Holding is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Iteos Therapeutics 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Iteos Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Iteos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

VectivBio Holding and Iteos Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VectivBio Holding and Iteos Therapeutics

The main advantage of trading using opposite VectivBio Holding and Iteos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VectivBio Holding position performs unexpectedly, Iteos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iteos Therapeutics will offset losses from the drop in Iteos Therapeutics' long position.
The idea behind VectivBio Holding AG and Iteos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk